The iron chelator pyridoxal isonicotinoyl hydrazone (PIH) and its analogues prevent damage to 2-deoxyribose mediated by ferric iron plus ascorbate.
Iron chelating agents are essential for treating iron overload in diseases such as beta-thalassemia and are potentially useful for therapy in non-iron overload conditions, including free radical mediated tissue injury. Deferoxamine (DFO), the only drug available for iron chelation therapy, has a number of disadvantages (e.g., lack of intestinal absorption and high cost). The tridentate chelator pyridoxal isonicotinoyl hydrazone (PIH) has high iron chelation efficacy in vitro and in vivo with high selectivity and affinity for iron. It is relatively non-toxic, economical to synthesize and orally effective. We previously demonstrated that submillimolar levels of PIH and some of its analogues inhibit lipid peroxidation, ascorbate oxidation, 2-deoxyribose degradation, plasmid DNA strand breaks and 5,5-dimethylpyrroline-N-oxide (DMPO) hydroxylation mediated by either Fe(II) plus H(2)O(2) or Fe(III)-EDTA plus ascorbate. To further characterize the mechanism of PIH action, we studied the effects of PIH and some of its analogues on the degradation of 2-deoxyribose induced by Fe(III)-EDTA plus ascorbate. Compared with hydroxyl radical scavengers (DMSO, salicylate and mannitol), PIH was about two orders of magnitude more active in protecting 2-deoxyribose from degradation, which was comparable with some of its analogues and DFO. Competition experiments using two different concentrations of 2-deoxyribose (15 vs. 1.5 mM) revealed that hydroxyl radical scavengers (at 20 or 60 mM) were significantly less effective in preventing degradation of 2-deoxyribose at 15 mM than 2-deoxyribose at 1.5 mM. In contrast, 400 microM PIH was equally effective in preventing degradation of both 15 mM and 1.5 mM 2-deoxyribose. At a fixed Fe(III) concentration, increasing the concentration of ligands (either EDTA or NTA) caused a significant reduction in the protective effect of PIH towards 2-deoxyribose degradation. We also observed that PIH and DFO prevent 2-deoxyribose degradation induced by hypoxanthine, xanthine oxidase and Fe(III)-EDTA. The efficacy of PIH or DFO was inversely related to the EDTA concentration. Taken together, these results indicate that PIH (and its analogues) works by a mechanism different than the hydroxyl radical scavengers. It is likely that PIH removes Fe(III) from the chelates (either Fe(III)-EDTA or Fe(III)-NTA) and forms a Fe(III)-PIH(2) complex that does not catalyze oxyradical formation.
Hermes-Lima
M
M
Oxyradical Research Group, Departamento de Biologia Celular, Universidade de Brasília, Brasília, Brazil. hermes@unb.br
Ponka
P
P
Schulman
H M
HM
D001205:Ascorbic Acid; D002614:Chelating Agents; D004249:DNA Damage; D003855:Deoxyribose / Q000737:chemistry*; D004121:Dimethyl Sulfoxide; D004492:Edetic Acid; D005290:Ferric Compounds; D016166:Free Radical Scavengers; D017665:Hydroxyl Radical; D007538:Isoniazid / Q000031:analogs & derivatives*; D007700:Kinetics; D008956:Models, Chemical; D010957:Plasmids; D011730:Pyridoxal / Q000031:analogs & derivatives*; D013329:Structure-Activity Relationship
D002614:Chelating Agents; D005290:Ferric Compounds; D016166:Free Radical Scavengers; D017665:Hydroxyl Radical; D011730:Pyridoxal; D003855:Deoxyribose; C021079:pyridoxal isonicotinoyl hydrazone; C061126:iron(III)-ascorbic acid complex; D004492:Edetic Acid; D001205:Ascorbic Acid; D007538:Isoniazid; D004121:Dimethyl Sulfoxide